GL1X · GenesisL1 explorer

MolNFT v1 · #151381 · protein

Crystal structure of spleen tyrosine kinase (syk) in complex with a 2- (PHENOXYMETHYL)PYRIDINE inhibitor

6HM7 · Tyrosine-protein kinase syk: “Crystal structure of spleen tyrosine kinase (syk) in complex with a 2- (PHENOXYMETHYL)PYRIDINE inhibitor”. X-ray diffraction, 2 ligands (GDH, BR), 3 pockets (best druggability 0.57). MolNFT v1 #151381…

PDB
6HM7
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase syk
EC
2.7.10.2
UniProt
P43405
Ligands
GDH, BR
Pockets
3 · best druggability 0.57

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase syk (EC 2.7.10.2)protein26841% helix, 21% strandP43405

Ligands and binding sites

  • GDH · 7-[2-methoxy-6-[(4-methylpyridin-2-yl)methoxy]phenyl]-2,3,4,5-tetrahydro-1~{H}-3-benzazepine · ligand · chains A
  • BR · Bromide ion · ion · 3 copies · chains A
  • GOL · Glycerol · additive · chains A
  • DMS · Dimethyl sulfoxide · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12140.570.7926GDH
2730.360.7714empty
3620.300.7516empty

Modifications

Observed in the structure: 1 modified (phosphorylation).

Compared structures

  • 6HM7 · Crystal structure of spleen tyrosine kinase (syk) in complex with a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.